UBALD2: A Potential Drug Target in Cellular Processes (G283991)

Target Name: UBALD2

NCBI ID: G283991

UBALD2

UBALD2: A Potential Drug Target in Cellular Processes

UBALD2 (Ubiquity Domain-Linked Abstracting and Retrieval) is a protein that is expressed in various tissues of the human body. It is a member of the superfamily of proteins known as the ubiquitin-like domains (UBD) and is characterized by the presence of a hydrophobic domain, a putative transmembrane region, and a cytoplasmic tail. UBALD2 has been shown to play a role in a variety of cellular processes, including cell adhesion, migration, and transcriptional regulation.

One of the most promising aspects of UBALD2 is its potential as a drug target. The ability of UBALD2 to interact with a variety of molecules, including transcription factors, cytokines, and signaling proteins, makes it an attractive target for the development of new therapeutic agents.

UBALD2 has been shown to interact with several transcription factors, including NF-kappa-B, AP-1, and STAT3. These interactions play a role in the regulation of cellular processes such as cell adhesion, migration, and transcriptional regulation. For example, UBALD2 has been shown to interact with NF-kappa-B and to regulate the expression of genes involved in cell adhesion and migration.

In addition to its role in cell adhesion and migration, UBALD2 has also been shown to play a role in the regulation of inflammation and immune response. For example, UBALD2 has been shown to interact with the protein PD-L1 and to regulate the production of immune cells.

UBALD2 has also been shown to play a role in the regulation of metabolism and cellular signaling pathways. For example, UBALD2 has been shown to interact with the protein SIRT1 and to regulate the expression of genes involved in cellular signaling pathways.

In conclusion, UBALD2 is a protein that has been shown to play a role in a variety of cellular processes, including cell adhesion, migration, and transcriptional regulation. Its potential as a drug target makes it an attractive target for the development of new therapeutic agents. Further research is needed to fully understand the role of UBALD2 in cellular processes and to develop effective therapies based on its interactions with other molecules.

Protein Name: UBA Like Domain Containing 2

The "UBALD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBALD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets